These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 4556105)

  • 1. The influence of cyclophosphamide on the rejection of allogenic rat kidney transplants. An in vitro study of cell-bound and antibody-mediated immunity.
    Husberg BS
    Clin Exp Immunol; 1972 Apr; 10(4):697-711. PubMed ID: 4556105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro interaction of specifically-sensitized and non-sensitized lymphocytes with kidney cells from human renal homografts.
    Wolf JS; Fawley JC; Hume DM
    Transplant Proc; 1969 Mar; 1(1):328-30. PubMed ID: 4944237
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 5. in vitro quantitation of lymphocyte and serum cytotoxic activity following renal homograft rejection in man.
    Wolf JS; Fawley JC; Hume DM
    Transplant Proc; 1971 Mar; 3(1):449-52. PubMed ID: 4937916
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated immunity and blocking antibodies to renal allografts.
    Hellström I; Hellström KE
    Transplant Proc; 1972 Sep; 4(3):369-71. PubMed ID: 4562764
    [No Abstract]   [Full Text] [Related]  

  • 7. Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.
    Garovoy MR; Franco V; Zschaeck D; Carpenter CB; Strom TB; Merrill JP
    Lancet; 1973 Mar; 1(7803):573-6. PubMed ID: 4120643
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody-dependent cell-mediated cytotoxicity in prospective kidney transplant recipients.
    Lightbody JJ; Rosenberg JC
    J Immunol; 1974 Mar; 112(3):890-6. PubMed ID: 4590706
    [No Abstract]   [Full Text] [Related]  

  • 9. Mechanisms of kidney allograft rejection.
    Najarian JS; Foker JE
    Transplant Proc; 1969 Mar; 1(1):184-93. PubMed ID: 4944216
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated immunity in hyperacute kidney rejection: tests for detecting presensitization.
    Thomas FT; Thomas JM; Fawley JC; Volk M; Burke SG; Wolf JS; Lee HM
    Surg Forum; 1974; 25(0):270-3. PubMed ID: 4612774
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity during rejection and enhancement of allogeneic skin grafts in rats.
    Peter HH; Feldman JD
    J Exp Med; 1972 Jun; 135(6):1301-15. PubMed ID: 4554452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of rat renal allograft rejection by antibody against lymphocyte antigen receptors.
    McKearn TJ; Finnegan A; Neu MR; Fitch FW; Stuart FP
    Surg Forum; 1974; 25(0):263-5. PubMed ID: 4612772
    [No Abstract]   [Full Text] [Related]  

  • 14. Synergystic action of sera from transplant recipients and lymphocytes activated in vitro.
    Gordon J; MacDonald H; MacLean LD
    Transplant Proc; 1973 Mar; 5(1):429-31. PubMed ID: 4695951
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of cyclosporine on in situ cellular and humoral immune responses during allograft rejection.
    Orosz CG; Sirinek LP; Zinn NE; Ferguson RM
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1175-7. PubMed ID: 3274303
    [No Abstract]   [Full Text] [Related]  

  • 16. Demonstration and identification of cytotoxic antibodies and antibodies blocking the cell-mediated antitumor immunity against adenovirus type 12-induced tumors.
    Ankerst J
    Cancer Res; 1971 Jul; 31(7):997-1003. PubMed ID: 4327089
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent advances in the understanding of rejection.
    Hamburger J
    Adv Nephrol Necker Hosp; 1975; 5():101-14. PubMed ID: 127520
    [No Abstract]   [Full Text] [Related]  

  • 18. Direct and antibody-dependent LMC cross-matching in renal transplantation.
    d'Apice AJ; Perez G; Carpenter CB
    Transplant Proc; 1976 Mar; 8(1):115-9. PubMed ID: 769258
    [No Abstract]   [Full Text] [Related]  

  • 19. Presensitization and clinical kidney transplantation. II. Correlative studies of humoral and cellular immunity and clinical course.
    Myburgh JA; Maier G; Smit JA; Shapiro M; Meyers AM; Rabkin R; Van Blerk PJ; Jersky J
    Transplantation; 1974 Sep; 18(3):213-22. PubMed ID: 4607999
    [No Abstract]   [Full Text] [Related]  

  • 20. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
    Mayhew E; Bennett M
    Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.